Maria Q Marin
Overview
Explore the profile of Maria Q Marin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez C, Perdiguero B, Falqui M, Marin M, Becares M, Sorzano C, et al.
J Virol
. 2020 Oct;
95(2).
PMID: 33115866
Induction of the endogenous innate immune system by interferon (IFN) triggers the expression of many proteins that serve like alarm bells in the body, activating an immune response. After a...
2.
Marin M, Sliepen K, Garcia-Arriaza J, Koekkoek S, Perez P, Sorzano C, et al.
Vaccines (Basel)
. 2020 Aug;
8(3).
PMID: 32764419
Hepatitis C virus (HCV) represents a major global health challenge and an efficient vaccine is urgently needed. Many HCV vaccination strategies employ recombinant versions of the viral E2 glycoprotein. However,...
3.
Garcia-Arriaza J, Marin M, Merchan-Rubira J, Mascaraque S, Medina M, Avila J, et al.
Vaccines (Basel)
. 2020 Mar;
8(1).
PMID: 32183198
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive memory loss and cognitive decline that has been associated with an accumulation in the brain of intracellular neurofibrillary tangles...
4.
Perez P, Marin M, Lazaro-Frias A, Sorzano C, Gomez C, Esteban M, et al.
Vaccines (Basel)
. 2020 Feb;
8(1).
PMID: 32041218
Development of a safe and efficacious vaccine against the HIV/AIDS pandemic remains a major scientific goal. We previously described an HIV/AIDS vaccine based on the modified vaccinia virus Ankara (MVA)...
5.
Perez P, Marin M, Lazaro-Frias A, Sorzano C, Di Pilato M, Gomez C, et al.
Vaccines (Basel)
. 2019 Dec;
7(4).
PMID: 31817622
Highly attenuated poxviral vectors, such as modified vaccinia virus ankara (MVA), are promising vaccine candidates against several infectious diseases. One of the approaches developed to enhance the immunogenicity of poxvirus...
6.
Marin M, Perez P, Ljungberg K, Sorzano C, Gomez C, Liljestrom P, et al.
J Virol
. 2019 Jan;
93(7).
PMID: 30674625
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV) affecting 71 million people worldwide with no licensed vaccines that prevent infection. Here, we have generated four...
7.
Perez P, Marin M, Lazaro-Frias A, Jimenez de Oya N, Blazquez A, Escribano-Romero E, et al.
Sci Rep
. 2018 Nov;
8(1):17385.
PMID: 30478418
Zika virus (ZIKV) is a re-emerging mosquito-borne flavivirus that affects humans and can cause severe neurological complications, including Guillain-Barré syndrome and microcephaly. Since 2007 there have been three large outbreaks;...
8.
Marin M, Perez P, Gomez C, Sorzano C, Esteban M, Garcia-Arriaza J
Viruses
. 2018 Aug;
10(8).
PMID: 30096846
Hepatitis C virus (HCV) represents a major global health problem for which a vaccine is not available. Modified vaccinia virus Ankara (MVA)-HCV is a unique HCV vaccine candidate based in...